This review points out that use of a screening test for cancer introduces biases such as lead time, length time, and overdiagnosis, which are inherent in screening and lead to apparent improvement in survival, even when there may not be any. The bias effect on survival is what necessitates a randomized controlled trial to demonstrate a change in mortality not just survival. Lead-time bias describes the survival benefit of...